about
Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrestA universal assay for detection of oncogenic fusion transcripts by oligo microarray analysisComparing the normalization methods for the differential analysis of Illumina high-throughput RNA-Seq data.Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinomaIdentification and characterization of a novel group of legume-specific, Golgi apparatus-localized WRKY and Exo70 proteins from soybean.ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.From cytogenetics to next-generation sequencing technologies: advances in the detection of genome rearrangements in tumors.Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinomaRNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma.Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies.Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma.Genotypic and phenotypic classification of cancer: How should the impact of the two diagnostic approaches best be balanced?Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.
P2860
Q24623859-52C6812A-1DED-409D-9153-5C544BACFB58Q24642548-7EE88D03-A0FB-4A46-B2A9-40A84DF54847Q31012573-08416077-97EF-4D49-B66C-2B4F39134CB1Q35145001-320ED6DF-79D7-4D14-965B-A4A6208A04EDQ35666788-E4F655DE-20AE-444B-8808-9451F3233C31Q36710981-F16505A7-1DEF-4E1C-8E5E-D21FC50BE910Q37149910-4C90EFEA-77E0-413F-9375-CB8D4C17B992Q37249560-BB738EE1-A907-48D5-9D49-F824296FF014Q37554783-0138B302-0546-434B-88B3-F79127D99E8AQ37772446-279BB005-D845-449E-B705-A9583F860CF5Q38441002-AA213256-BE89-42AF-90FC-47774F081AEAQ38505827-DEFBA449-BF97-4E2D-A8AE-CB1F80C7A2ECQ42807725-B5519288-E4F3-4392-B774-CF408D6AAE3A
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Recurrent fusion oncogenes in carcinomas.
@ast
Recurrent fusion oncogenes in carcinomas.
@en
Recurrent fusion oncogenes in carcinomas.
@nl
type
label
Recurrent fusion oncogenes in carcinomas.
@ast
Recurrent fusion oncogenes in carcinomas.
@en
Recurrent fusion oncogenes in carcinomas.
@nl
prefLabel
Recurrent fusion oncogenes in carcinomas.
@ast
Recurrent fusion oncogenes in carcinomas.
@en
Recurrent fusion oncogenes in carcinomas.
@nl
P1476
Recurrent fusion oncogenes in carcinomas.
@en
P2093
Manuel R Teixeira
P304
P356
10.1615/CRITREVONCOG.V12.I3-4.40
P407
P577
2006-12-01T00:00:00Z